[
  {
    "": 0,
    "Gene name": "PROM1",
    "Genomic Position": "4:15969857-16085324(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Hepatocellular Carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Sorafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22596232"
  },
  {
    "": 1,
    "Gene name": "ROM1",
    "Genomic Position": "11:62380213-62382592(+)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Hepatocellular Carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Sorafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22596232"
  },
  {
    "": 2,
    "Gene name": "FGF1",
    "Genomic Position": "5:141971743-142000907(-)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Hepatocellular Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575541"
  },
  {
    "": 3,
    "Gene name": "SI",
    "Genomic Position": "3:164696686-164796283(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Hepatocellular Carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Sorafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22596232"
  },
  {
    "": 4,
    "Gene name": "KRAS",
    "Genomic Position": "12:25362365-25403737(-)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Hepatocellular Carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Refametinib + Sorafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT01915602"
  },
  {
    "": 5,
    "Gene name": "KRAS",
    "Genomic Position": "12:25362365-25403737(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Refametinib + Sorafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT01915602"
  },
  {
    "": 6,
    "Gene name": "KRAS",
    "Genomic Position": "12:25362365-25403737(-)",
    "CDS Mutation": "c.35G>A",
    "AA Mutation": "p.G12D",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Refametinib + Sorafenib",
    "Description": "",
    "rs value": 121913529,
    "pmid": "PubMed:NCT01915602"
  },
  {
    "": 7,
    "Gene name": "FGF19",
    "Genomic Position": "11:69513000-69519410(-)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Hepatocellular Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575541"
  },
  {
    "": 8,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified_or_BRCA2_unspecified",
    "AA Mutation": "unspecified_or_BRCA2_unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 0,
    "Response to Drug": "Sensitivity",
    "Therapies": "Temozolomide + Veliparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01205828"
  },
  {
    "": 9,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Varlitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03499626"
  },
  {
    "": 10,
    "Gene name": "AFP",
    "Genomic Position": "4:74301880-74321891(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Best supportive care + Ramucirumab",
    "Description": "",
    "rs value": "",
    "pmid": "FDA drug label:NCT02435433"
  },
  {
    "": 11,
    "Gene name": "TERT",
    "Genomic Position": "5:1253282-1295162(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "RZ001",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05595473"
  },
  {
    "": 12,
    "Gene name": "EGFR",
    "Genomic Position": "7:55086794-55279321(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Varlitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03499626"
  },
  {
    "": 13,
    "Gene name": "ERBB3",
    "Genomic Position": "12:56473645-56497289(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Varlitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03499626"
  },
  {
    "": 14,
    "Gene name": "ERBB4",
    "Genomic Position": "2:212240446-213403565(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Varlitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03499626"
  },
  {
    "": 15,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "unspecified_and_KLB_unspecified",
    "AA Mutation": "unspecified_and_KLB_unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 16,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.V550L",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 17,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.V510L",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 18,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.V510M",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 19,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.V550M",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 20,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1648G>T",
    "AA Mutation": "p.V550L",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 21,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1444G>T",
    "AA Mutation": "p.V482L",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 22,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1528G>T",
    "AA Mutation": "p.V510L",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 23,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1444G>A",
    "AA Mutation": "p.V482M",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 24,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1534T>C",
    "AA Mutation": "p.C512R",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 25,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1654T>C",
    "AA Mutation": "p.C552R",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 26,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1648G>A",
    "AA Mutation": "p.V550M",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 27,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1528G>A",
    "AA Mutation": "p.V510M",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 28,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1648G>C",
    "AA Mutation": "p.V550L",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 29,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1528G>C",
    "AA Mutation": "p.V510L",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 30,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1450T>C",
    "AA Mutation": "p.C484R",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 31,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.1444G>C",
    "AA Mutation": "p.V482L",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 32,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.C552F",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 33,
    "Gene name": "FGFR4",
    "Genomic Position": "5:176513887-176525145(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.C512F",
    "Disease": "hepatocellular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fisogatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31575540"
  },
  {
    "": 34,
    "Gene name": "ALK",
    "Genomic Position": "2:29415640-30144432(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Ascrinvacumab",
    "Description": "",
    "rs value": "",
    "pmid": "Unindexed journals, Conference abstracts:NCT01911273"
  },
  {
    "": 35,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "rAD-p53",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02418988"
  },
  {
    "": 36,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Nivolumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02576509"
  },
  {
    "": 37,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Nivolumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02576509"
  },
  {
    "": 38,
    "Gene name": "NOTCH1",
    "Genomic Position": "9:139388896-139440314(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Ginsenoside Rg3 capsule + Pirarubicin",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02724358"
  },
  {
    "": 39,
    "Gene name": "KIT",
    "Genomic Position": "4:55524085-55606881(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Sunitinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT00247676"
  },
  {
    "": 40,
    "Gene name": "JAK2",
    "Genomic Position": "9:4985245-5128183(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "AZD1480",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT01219543"
  },
  {
    "": 41,
    "Gene name": "MET",
    "Genomic Position": "7:116312459-116436396(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Tivantinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02029157"
  },
  {
    "": 42,
    "Gene name": "MET",
    "Genomic Position": "7:116312459-116436396(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "liver / carcinoma / hepatocellular carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Tivantinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02029157"
  }
]
